Novo Nordisk drug shows better weight loss results than Zepbound in trial
Novo Nordisk announced that its next-generation weight loss medication helped patients lose more weight than Zepbound during a recent major clinical trial.
Novo Nordisk announced that its next-generation weight loss medication helped patients lose more weight than Zepbound during a recent major clinical trial.
Researchers at the European Association for the Study of Diabetes in Milan reported that people with diabetes sometimes felt better when their blood sugar fluctuated within safe limits rather than staying perfectly steady.
Experts warn that health insurance provided by employers will face even more severe challenges in 2027 compared to current conditions.
Results for the Medical and Dental College Admission Test in Sindh have been released showing strong performance from Tharparkar candidates.
GoFundMe removed a fundraising page for a man paying his wife's cancer bills because the platform found factual misrepresentations in the parents' story.
A major review of data from over 2.8 million children in 64 countries suggests high screen usage correlates with worse developmental results.
The Trump administration asked the Supreme Court on Monday to allow federal prison officials to restrict gender-affirming care for transgender inmates.
Indian authorities in Tamil Nadu state distributed one-gramme gold rings to babies born in government-run hospitals on Monday.
A University of British Columbia study finds consumers associate shorter product shelf lives with natural foods despite unreliable indicators.
A former student with social anxiety describes how a therapist helped her overcome fear by asking two specific questions before she returned to the world.